Search results for " biopharma" in Articles / App Notes

Article Get Confident: Inline Conditioning Control Modes
CLICK HERE TO LEARN MORE >> In this course, you will learn how to use the control modes of the BioProcess Inline Conditioning (IC) system used for buffer preparation. The control modes are the s…

Article Can Vaccine Development Be Safely Accelerated?
Can Vaccine Development Be Safely Accelerated? Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe. By Cynthia A. Ch…

Article Free On-Demand Webinar: Smart Process Development of Chromatography Steps
Smarter development of chromatography processes reduces timelines and improves outcomes.  Smart process development is a collection of approaches to improve and speed up process development—prov…

Article Monitoring and Control of Inline Dilution Processes
Challener Process intensification is a major focus of the biopharma industry, with most efforts targeting upstream cell culture and associated processes. Buffer management has received les…

Article Single-Use for Downstream Chromatography: Benefit or Hindrance?
Resin fouling Another unmet need for biopharmaceutical manufacturers is technology that reduces the cost of resins (3), to allow for greater use of single-use systems to address the resin fouling t…

Article Why, Why, Why…ELISA? A Look at the Benchmark HCP Assay
Click here to read the article >> Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytica…

Article Bispecific Antibody Purification: Insights and Case Studies
New modalities, like bispecific antibodies, present unique challenges compared to mAb production. For purification, there’s not just one right answer to which strategy to use. Here are some industry…

Article Modeling the Degradation of mAb Therapeutics
This is particularly true for monoclonal antibodies (mAbs), which account for most commercial biopharmaceuticals today. Both physical effects such as aggregation and chemical modifications (e.g., frag…

Article Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
These new “rapid” dyes are becoming increasingly popular in many biopharma glycoprofiling workflows due to their inclusion in commercial sample preparation kits (e.g., GlycoWorks, Waters and GlycoPrep…

Article The Challenge of Disruptive Technologies in Bioprocessing
“When we look at the biologics market dynamics for treatment of diseases, certainly the increasing demand for biopharmaceuticals and the growing R&D expenditure in biopharma companies are factors driv…

Show All Results

Previous PageNext Page